Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

ClinicalTrials.gov ID: NCT01307267

Public ClinicalTrials.gov record NCT01307267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1 STUDY OF PF-05082566 AS A SINGLE AGENT IN PATIENTS WITH ADVANCED CANCER, AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL)

Study identification

NCT ID
NCT01307267
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
190 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2011
Primary completion
Feb 19, 2019
Completion
Feb 19, 2019
Last update posted
Mar 16, 2020

2011 – 2019

United States locations

U.S. sites
35
U.S. states
9
U.S. cities
18
Facility City State ZIP Site status
City of Hope Duarte California 91010
UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla California 92037-0845
UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla California 92037
UC San Diego Moores Cancer Center La Jolla California 92093
Research Administration Office: Clinical Research Unit Los Angeles California 90095
Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles California 90095
UCLA Bowyer Clinic Los Angeles California 90095
UCLA Hematology-Oncology Clinic Los Angeles California 90095
Stanford University Medical Center Palo Alto California 94304
Stanford University Medical Center Palo Alto California 94305
UC San Diego Medical Center - Hillcrest San Diego California 92103
Santa Monica UCLA Hematology & Oncology Clinic Santa Monica California 90404
Stanford University Medical Center Stanford California 94305
Georgetown University Medical Center Department of Pharmacy, Research Washington D.C. District of Columbia 20007
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007
Emory University Hospital Midtown Atlanta Georgia 30308
Emory University Hospital Atlanta Georgia 30322
The Emory Clinic, Building A Atlanta Georgia 30322
The Emory Clinic Atlanta Georgia 30322
Winship Cancer Institute Atlanta Georgia 30322
Brigham and Woman's Hospital Boston Massachusetts 02115
Dana-Farber Cancer Institute Boston Massachusetts 02215
University of Michigan Health System Ann Arbor Michigan 48109
Siteman Cancer Center - St. Peters City of Saint Peters Missouri 63376
Siteman Cancer Center-West County Creve Coeur Missouri 63141
Barnes-Jewish Hospital St Louis Missouri 63110-1094
Barnes-Jewish Hospital St Louis Missouri 63110
Washington University Infusion Center Pharmacy St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Siteman Cancer Center- South County St Louis Missouri 63129
Memorial Sloan Kettering Cancer Center New York New York 10065
The University of Texas - M.D. Anderson Cancer Center Houston Texas 77030
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229
Seattle Cancer Care Alliance Seattle Washington 98109
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01307267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01307267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →